Literature DB >> 21489623

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

Sarah Clarke, John O'Reilly, Giuliana Romeo, Julian Cooney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21489623     DOI： 10.1016/j.leukres.2011.03.025

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  13 in total

1.  Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.

Authors:  S Koschmieder; T Burmeister; M Brüggemann; A Berkemeier; S Volpert; P Wieacker; G Silling; N Gökbuget; C Müller-Tidow; W E Berdel; M Stelljes
Journal:  Leukemia       Date:  2013-09-19       Impact factor: 11.528

2.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Authors:  Shannon L Maude; Sibasish Dolai; Cristina Delgado-Martin; Tiffaney Vincent; Alissa Robbins; Arthavan Selvanathan; Theresa Ryan; Junior Hall; Andrew C Wood; Sarah K Tasian; Stephen P Hunger; Mignon L Loh; Charles G Mullighan; Brent L Wood; Michelle L Hermiston; Stephan A Grupp; Richard B Lock; David T Teachey
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

Review 3.  Relapsed T Cell ALL: Current Approaches and New Directions.

Authors:  Christine M McMahon; Selina M Luger
Journal:  Curr Hematol Malig Rep       Date:  2019-04       Impact factor: 3.952

Review 4.  Can one target T-cell ALL?

Authors:  Adolfo Ferrando
Journal:  Best Pract Res Clin Haematol       Date:  2018-10-17       Impact factor: 3.020

5.  NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins.

Authors:  Kim De Keersmaecker; Michaël Porcu; Luk Cox; Tiziana Girardi; Roel Vandepoel; Joyce Op de Beeck; Olga Gielen; Nicole Mentens; Keiryn L Bennett; Oliver Hantschel
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

Review 6.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

7.  NUP214 fusion genes in acute leukemia (Review).

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

8.  Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.

Authors:  Carolina Simioni; Simona Ultimo; Alberto M Martelli; Giorgio Zauli; Daniela Milani; James A McCubrey; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2016-11-29

9.  Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.

Authors:  Rima Koka; Najeebah A Bade; Edward A Sausville; Yi Ning; Ying Zou
Journal:  Mol Cytogenet       Date:  2017-10-26       Impact factor: 2.009

10.  Case Report: The First Report of NUP214-ABL1 Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.

Authors:  Huan-Ping Wang; Jun-Jun He; Qiao-Yun Zhu; Lin Wang; Jian-Hu Li; Jian-Song Huang; Wan-Zhuo Xie; Hong-Hu Zhu; Jie Jin
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.